The development of psilocybin therapy for treatment-resistant depression: an update
BJPsych Bulletin June 26, 2023 Anya Borissova, James J. Rucker 16 citations
Summary Psilocybin is a classic psychedelic drug that has attracted increasing research interest over the past 10 years as a possible treatment for mood, anxiety and related conditions. Initial phase 2 clinical trials of psilocybin given alongside psychological support for major depression and treatment-resistant depression (TRD) demonstrated encouraging signs of basic safety, further confirmed...